Abstract:Ginseng fruit saponins (GFS) extracted from the ginseng fruit are the bioactive triterpenoid saponin components. The aim of the present study was to develop a drug delivery system called proliposome using sodium deoxycholate (NaDC) as a bile salt to improve the oral bioavailability of GFS in rats. The liposomes of GFS were prepared by a conventional ethanol injection and formed the solid proliposomes (P-GFS) using spray drying method on mannitol carriers. The formulation of P-GFS was optimized using the response surface methodology. The physicochemical properties of liposome suspensions including encapsulation efficiency, in vitro drug release studies, particle size of the reconstituted liposome were tested. The solid state characterization studies using the method of Field emission-scanning electron microscope (FE-SEM), Fourier transform infrared (FT-IR) and Differential scanning colorimetric (DSC) were tested to study the molecular state of P-GFS and to indicate the interactions among the formulation ingredients. In vitro studies showed a delayed release of ginsenoside Re (GRe). In vivo studies were carried out in rats. The concentrations of GRe in plasma of rats and its pharmacokinetic behaviors after oral administration of GFS, Zhenyuan tablets (commercial dosage form of GFS) and P-GFS were studied using ultra performance liquid chromatography tandem mass spectrometry. It was founded that the GRe concentration time curves of GFS, Zhenyuan tablets and P-GFS were much more different in rats. Pharmacokinetic behaviors of P-GFS showed a second absorption peak on the concentration time curve. The pharmacokinetic parameters of GFS, Zhenyuan tablets, P-GFS in rats were separately listed as follows: T max 0.25h, C max 474.96±66.06ng/ml and AUC0−∞ 733.32±113.82ng/mlh for GFS; T max 0.31±0.043h, C max 533.94±106.54ng/ml and AUC0−∞ 1151.38±198.29ng/mlh for Zhenyuan tablets; T max 0.5h, C max 680.62±138.051ng/ml and AUC0−∞ 2082.49±408.33ng/mlh for the P-GFS. The bioavailability of P-GFS was nearly 284% and 181% of the GFS and Zhengyuan tablets respectively. In conclusion, the proliposomes significantly enhanced the drug bioavailability, absorption in the gastrointestinal tract and decreased its elimination time of GRe in rats and could be selectively applied for oral delivery of GFS.

Proliposomes containing a bile salt for oral delivery of Ginkgo biloba extract: Formulation optimization, characterization, oral bioavailability and tissue distribution in rats

Oleic Acid Derivative of Polyethylenimine-Functionalized Proliposomes for Enhancing Oral Bioavailability of Extract of Ginkgo Biloba

Comparative pharmacokinetics of a proliposome formulation of Ginkgo biloba extract and Ginaton in rats by a sensitive ultra performance liquid chromatography–tandem mass spectrometry method

Improvement of Oral Availability of Ginseng Fruit Saponins by a Proliposome Delivery System Containing Sodium Deoxycholate

Development of a novel niosomal system for oral delivery of Ginkgo biloba extract.

Glycyrrhizic Acid-Phospholipid Complex: Preparation Process Optimization and Therapeutic and Pharmacokinetic Evaluation in Rats

Optimization of the Preparation Conditions of Borneol-Modified Ginkgolide Liposomes by Response Surface Methodology and Study of Their Blood Brain Barrier Permeability

Enhanced dissolution rate and oral bioavailability of Ginkgo biloba extract by preparing solid dispersion via hot-melt extrusion

Self-microemulsifying Sustained-Release Pellet of Ginkgo Biloba Extract: Preparation, in Vitro Drug Release and Pharmacokinetics Study in Beagle Dogs

Preparation and evaluation of proliposomes formulation for enhancing the oral bioavailability of ginsenosides

Enhanced Dissolution Rate And Oral Bioavailability Of Ginkgo Biloba Extract By Preparing Nanoparticles Via Emulsion Solvent Evaporation Combined With Freeze Drying (Ese-Fr)

Design of novel proliposome formulation for antioxidant peptide, glutathione with enhanced oral bioavailability and stability

Enhanced Bioaccessibility In Vitro And Bioavailability Of Ginkgo Biloba Extract Nanoparticles Prepared By Liquid Anti-Solvent Precipitation

Comparative Pharmacokinetics and Bioavailability Studies of Quercetin, Kaempferol and Isorhamnetin after Oral Administration of Ginkgo Biloba Extracts, Ginkgo Biloba Extract Phospholipid Complexes and Ginkgo Biloba Extract Solid Dispersions in Rats.

Preparation of PEGylated Liposomal Ginsenoside;Formulation Design and in Vitro Evaluation

Enhanced Bioavailability of the Poorly Water-Soluble Drug Fenofibrate by Using Liposomes Containing a Bile Salt

Preparation and Transdermal Diffusion of Flexible Nanoliposomes of Ginkgolid B.

Proliposomes for Oral Delivery of Total Biflavonoids Extract from Selaginella Doederleinii: Formulation Development, Optimization, and in Vitro-in Vivo Characterization.

Fabrication and characterization of TPGS-modified chlorogenic acid liposomes and its bioavailability in rats

The Use of Lipid-Based Formulations to Increase the Oral Bioavailability of Panax Notoginseng Saponins Following a Single Oral Gavage to Rats